Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B

Mise à jour : Il y a 4 ans
Référence : NCT00877760

Femme et Homme

Extrait

The purpose of this study is to investigate whether it is possible to augment the response of patients with HBeAg-positive chronic hepatitis B to entecavir by using a temporary peginterferon alpha-2a add-on strategy


Critère d'inclusion

  • Chronic hepatitis B


Liens